NanoViricides raises $6M in registered direct offering and private placement with warrants

NANOVIRICIDES, INC.

Offered 3,571,429 shares (or pre-funded equivalents) at $1.68/share for gross proceeds of ~$6M.
Concurrent private placement of Series A warrants (3.57M shares, $1.75 exercise, 2yr) and Series B warrants (3.57M shares, $2.00 exercise, 5.5yr).
Offering closed Nov 12, 2025; net proceeds for working capital and general corporate purposes.
Directors and executive officers entered into 90-day lock-up agreements following closing.
A.G.P./Alliance Global Partners acted as sole placement agent with 7% cash fee.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

NANOVIRICIDES, INC. issued Series A Common Stock Purchase Warrants to purchase up to 3,571,429 shares of Common Stock and Series B Common Stock Purchase Warrants to purchase up to 3,571,4 of warrant to a certain institutional investor.

Security: warrant
Shares: Series A Common Stock Purchase Warrants to purchase up to 3,571,429 shares of Common Stock and Series B Common Stock Purchase Warrants to purchase up to 3,571,4
Purchaser: a certain institutional investor

Exact text from the filing

The information contained above in Item 1.01 relating to the issuance of the Common Warrants and the shares of Common Stock issuable thereunder is hereby incorporated by reference into this Item 3.02.

View on SEC.gov

19 equity issuances filed in the last 30 days. Browse all equity issuances →

NANOVIRICIDES, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-112644

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.